Filing search / Notable Labs, Ltd. / "Innovative"

S-1/A

NTBL Notable Labs, Ltd.

1 Jul 24

IPO registration (amended)

5:19pm

our business, results of operations and prospects. Our approach to the discovery and development of drug candidates based on the PMP is innovative … is a powerful strategy, our approach is both innovative and in the early stages of development. Because our approach is both innovative and in the early

S-1

NTBL Notable Labs, Ltd.

20 Jun 24

IPO registration

5:01pm

approach to the discovery and development of drug candidates based on the PMP is innovative and in the early stages of development; and we do not know … of action, potential combination drug usage and potentially responsive patient population is a powerful strategy, our approach is both innovative

8-K

EX-99.1

2z0mggt2b

8 Apr 24

Other Events

12:15pm

424B3

ovef55mqk11i

5 Sep 23

Prospectus supplement

6:02pm

S-4/A

msja 419w9jwfi4

30 Jun 23

Registration of securities issued in business combination transactions (amended)

4:38pm

S-4

nufirq8wpz0sgk gkyxm

11 May 23

Registration of securities issued in business combination transactions

9:09am

6-K

uqrbxlem2kslk37na0rr

16 Aug 18

Current report (foreign)

7:00am